IXJ vs. GERM
IXJ (iShares Global Healthcare ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds - IXJ tracks the S&P Global Healthcare Sector Index while GERM tracks the Prime Treatments, Testing and Advancements Index. Both are passively managed. Over the past year, IXJ returned 9.30% vs 0.00% for GERM. IXJ charges 0.46%/yr vs 0.68%/yr for GERM.
Performance
IXJ vs. GERM - Performance Comparison
Loading charts...
Returns By Period
IXJ
- 1D
- 0.39%
- 1M
- 0.34%
- YTD
- -5.26%
- 6M
- -4.88%
- 1Y
- 9.30%
- 3Y*
- 4.42%
- 5Y*
- 4.02%
- 10Y*
- 7.66%
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IXJ vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
IXJ iShares Global Healthcare ETF | -5.26% | 14.99% | -12.26% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
IXJ vs. GERM - Sectors Allocation Comparison
Sectors
IXJ
GERM
Healthcare
Consumer Defensive
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IXJ
GERM
Consumer Defensive
IXJ
GERM
-
Basic Materials
IXJ
-
GERM
-
Communication Services
IXJ
-
GERM
-
Consumer Cyclical
IXJ
-
GERM
-
Energy
IXJ
-
GERM
-
Financial Services
IXJ
-
GERM
Industrials
IXJ
-
GERM
-
Real Estate
IXJ
-
GERM
-
Technology
IXJ
-
GERM
-
Utilities
IXJ
-
GERM
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IXJ vs. GERM — Risk / Return Rank
IXJ
GERM
IXJ vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IXJ | GERM | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.64 | — | — |
Sortino ratioReturn per unit of downside risk | 1.06 | — | — |
Omega ratioGain probability vs. loss probability | 1.12 | — | — |
Calmar ratioReturn relative to maximum drawdown | 0.87 | — | — |
Martin ratioReturn relative to average drawdown | 2.11 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IXJ | GERM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.64 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.49 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | — | — |
Drawdowns
IXJ vs. GERM - Drawdown Comparison
The maximum IXJ drawdown since its inception was -40.60%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for IXJ and GERM.
Loading charts...
Drawdown Indicators
| IXJ | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.60% | 0.00% | -40.60% |
Max Drawdown (1Y)Largest decline over 1 year | -10.78% | 0.00% | -10.78% |
Max Drawdown (3Y)Largest decline over 3 years | -18.14% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -18.14% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -27.35% | — | — |
Current DrawdownCurrent decline from peak | -9.27% | 0.00% | -9.27% |
Average DrawdownAverage peak-to-trough decline | -6.92% | 0.00% | -6.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.41% | 0.00% | +4.41% |
Volatility
IXJ vs. GERM - Volatility Comparison
iShares Global Healthcare ETF (IXJ) has a higher volatility of 3.75% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that IXJ's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IXJ | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.75% | 0.00% | +3.75% |
Volatility (6M)Calculated over the trailing 6-month period | 10.05% | 0.00% | +10.05% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.55% | 0.00% | +14.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.21% | 0.00% | +14.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.67% | 0.00% | +15.67% |
IXJ vs. GERM - Expense Ratio Comparison
IXJ has a 0.46% expense ratio, which is lower than GERM's 0.68% expense ratio.
Dividends
IXJ vs. GERM - Dividend Comparison
IXJ's dividend yield for the trailing twelve months is around 1.47%, while GERM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IXJ iShares Global Healthcare ETF | 1.47% | 1.40% | 1.50% | 1.38% | 1.17% | 1.12% | 1.27% | 1.42% | 2.11% | 1.46% | 1.73% | 2.85% |
Frequently Asked Questions
IXJ has higher volatility (3.75%) compared to GERM (0.00%). In terms of maximum drawdown, IXJ dropped -40.60% vs GERM's 0.00%.
On 1-year performance, IXJ leads with 9.30% vs 0.00% for GERM. On fees, IXJ is cheaper at 0.46% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, IXJ has performed better with a 9.30% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IXJ is cheaper with a 0.46% expense ratio, compared with 0.68% for GERM.
IXJ has the higher dividend yield at 1.47%, compared with 0.00% for GERM.
IXJ tracks S&P Global Healthcare Sector Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: iShares and Amplify. Their fees differ too: 0.46% for IXJ and 0.68% for GERM.
Find the right allocation for IXJ and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer